Home > Cashflow Statement > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Cashflow Statement

SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹344 Cr₹406 Cr₹560 Cr₹668 Cr₹468 Cr
Adjustment ₹60 Cr₹17 Cr₹37 Cr₹41 Cr₹36 Cr
Changes In working Capital ₹-32 Cr₹72 Cr₹5.77 Cr₹-194 Cr₹-12 Cr
Cash Flow after changes in Working Capital ₹372 Cr₹495 Cr₹603 Cr₹514 Cr₹492 Cr
Cash Flow from Operating Activities ₹288 Cr₹385 Cr₹457 Cr₹330 Cr₹383 Cr
Cash Flow from Investing Activities ₹-255 Cr₹-362 Cr₹-195 Cr₹-136 Cr₹-311 Cr
Cash Flow from Financing Activities ₹3.32 Cr₹-40 Cr₹-242 Cr₹-156 Cr₹-76 Cr
Net Cash Inflow / Outflow ₹36 Cr₹-18 Cr₹20 Cr₹37 Cr₹-4.51 Cr
Opening Cash & Cash Equivalents ₹47 Cr₹65 Cr₹45 Cr₹7.18 Cr₹12 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹1.99 Cr--₹0.00 Cr₹0.00 Cr
Closing Cash & Cash Equivalent ₹85 Cr₹47 Cr₹65 Cr₹45 Cr₹7.18 Cr

Compare Cashflow Statement of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹14,031.9 Cr -3.7% -28.5% -63.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 6.8% -1.5% -2.4% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 0% -4.8% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 1.7% 4.1% 20.5% Stock Analytics
CIPLA ₹107,075.0 Cr 0.1% -12.8% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 1.8% -0.7% 3.4% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-3.7%

-28.5%

-63.3%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses